Peptone glucose fluconazole agar, a selective medium for rapid and enhanced isolation of Aspergillus fumigatus from aqueous suspensions and sputum seeded with Candida albicans

Current Science

Volumn 88, Issue 3, 2005, Pages 449-454

  Randhawa, H S ^a   Kowshik, T ^a   Preeti Sinha, K ^a   Sandhu, R S ^a   Chowdhary, Anuradha ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; FUNGI;

EID: 20444382087     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Randhawa, H. S., Sandhu, R. S. and Kowshik, T., In vitro inhibition of Aspergillus fumigatus by Candida species, especially C. albicans and C. glabrata. Curr. Sci., 2002, 82, 860-865.
2. Rippon, J. W., Medical Mycology: The Pathogenic Fungi and The Pathogenic Actinomycetes, W.B. Saunders Co., Philadelphia, 1982, p.545.
3. Odds, F. C., Candida and Candidosis, W.B. Saunders Co., Orlando, Florida, 1988.
4. Becker, A., Akkad, N., Forster, D. H. and Kniehl, E., Growth of Aspergillus fumigatus is inhibited by Candida species on sealed Sabouraud agar plates but not on sealed Columbia agar plates. Clin. Microbiol. Infect., 2004, 10, Suppl. 3, p. 507.
5. Sarosi, G. A. and Davies, S. F., Fungal Diseases of the Lung, Lippincott Williams & Wilkins, Philadelphia, USA, 2000, p. 138.
6. Calliot, D. et al., Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J. Clin. Oncol., 1997, 15, 139-147.
7. Guillemain, R., Lavarde, V., Amrein, C., Chevalier, P., Guinvarch, A. and Glotz, D., Invasive aspergillosis after transplantation. Transplant Proc., 1995, 27, 1307-1309.
8. Hopwood, V., Johnson, E. M., Cornish, J. M., Foot, A. B. M., Evans, E. G. V. and Warnock, D. W., Use of the Pastorex Aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J. Clin. Pathol., 1995, 48, 210-213.
9. El-Ebiary, M. et al., Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. Am. J. Respir. Crit. Care Med., 1997, 156, 583-590.
10. Pittet, D., Monod, M., Suter, P. M., Frenk, E. and Auckenthaler, R., Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg., 1994, 220, 751-758.
11. Karlowsky, J. A., Zhanel, G. G., Balko, T. V., Zelenitsky, S. A., Kabani, A. M. and Hoban, D. J., In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus and Blastomyces species. Diagn. Microbiol. Infect. Dis., 1997, 28, 179-182.
12. Graybill, J. R., Revankar, S. G. and Patterson, T. F., Antifungal agents and antifungal susceptibility testing. In Topley & Wilson's Microbiology and Microbial Infections (eds Collier, L., Balows, A. and Sussman, M.), nineth edn. vol. 4;
13. Medical Mycology (eds Ajello, L. and Hay, R. J.), Arnold, London, 1998, p. 166.
14. Tawara, S. et al., In vitro activities of a new lipopeptide antifungal agent, FK 463, against a variety of clinically important fungi. Antimicrob. Agents Chemother., 2000, 44, 57-62.
15. de Hoog, G. S., Guarro, J., Gene, J. and Figueras, M. J., Atlas of Clinical Fungi, Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands/Universitat Rovira I Virgilli, Reus, Spain, 2000, pp. 643, 969.
16. Sojakova, M., Liptajova, D., Borovsky, M. and Subik, J., Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia, 2004, 157, 163-169.
17. Burns, J. and Larsh, H. W., Selective isolation of Histoplasma capsulatum in presence of Candida spp. Bact. Proc., 1962, p. 66.
18. Kapica, L., Shaw, C. E. and Bartlett, G. W., Inhibition of Histoplasma capsulatum by Candida albicans and other yeasts on Sabouraud's agar media. J. Bacteriol., 1968, 95, 2171-2176.
19. Smith, L. D. and Goodman, N. L., Improved culture method for the isolation of Histoplasma capsulatum and Blastomyces dermatitidis from contaminated specimens. Am. J. Clin. Pathol., 1975, 63, 276-280.
20. Restrepo, A. and Correa, I., Comparison of two culture media for primary isolation of Paracoccidioides brasiliensis from sputum. Sabouraudia, 1972, 10, 260-265.
21. Fischer, J. B. and Kane, J., The laboratory diagnosis of dermatophytosis complicated with Candida albicans. Can. J. Microbiol., 1974, 20, 167-182.
22. Kane, J., Blakeman, J. M. and Fischer, J. B., Tinea cruris: diagnostic confusion due to isolation of Candida albicans alone. Can. Med. Assoc. J., 1976, 114, 797-798.
23. Chaturvedi, S., Randhawa, H. S., Chaturvedi, V. P. and Khan, Z. U., Efficacy of brain heart infusion - egg albumen agar, yeast extract phosphate agar and peptone glucose agar media for isolation of Blastomyces dermatitidis from sputum. Mycopathologia, 1990, 112, 105-112.
24. King, R. D., Dillavou, C. L., Greenberg, J. H., Jeppsen, J. C. and Jaeger, J. S., Identification of carbon dioxide as a dermatophyte inhibitory factor produced by Candida albicans. Can. J. Microbiol., 1976, 22, 1720-1727.
25. Norris, H. A., Elewski, B. E. and Ghannoum, M. A., Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J. Am. Acad. Dermatol., 1999, 40, 9-13.
26. Ghannoum, M. A., Bradley, M., Isham, N., Leidich, S. and Elweski, B., Genetic relatedness and antifungal susceptibilities of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses, 1999, 42, 134.